Investigators who plan to conduct or engage in COVID-19 human subjects research are required to obtain authorization prior to IRB submission.

Read more. More

This site provides information on the conduct of human subjects research and FDA-regulated clinical trials during the COVID-19 pandemic.  Operational changes to the UW-Madison and UW Health clinical research infrastructure programs (e.g., Office of Clinical Trials, Pharmaceutical Research Center, Clinical Research Unit) will be regularly updated.  Additionally, this site will share best practices and resources across the many UW-Madison schools, colleges, and departments that conduct human subjects research.